K Pharma,Inc. (4896.T)

JPY 756.0

(-1.82%)

Revenue Summary of K Pharma,Inc.

  • K Pharma,Inc.'s latest annual revenue in 2023 was 1 Billion JPY , down 0.0% from previous year.
  • K Pharma,Inc.'s latest quarterly revenue in 2024 Q2 was - JPY , down 0.0% from previous quarter.
  • K Pharma,Inc. reported a annual revenue of - JPY in annual revenue 2022, down 0.0% from previous year.
  • K Pharma,Inc. reported a annual revenue of - JPY in annual revenue 2021, down 0.0% from previous year.
  • K Pharma,Inc. reported a quarterly revenue of - JPY for 2024 Q1, down 0.0% from previous quarter.
  • K Pharma,Inc. reported a quarterly revenue of - JPY for 2023 Q3, down 0.0% from previous quarter.

Annual Revenue Chart of K Pharma,Inc. (2023 - 2021)

Historical Annual Revenue of K Pharma,Inc. (2023 - 2021)

Year Revenue Revenue Growth
2023 1 Billion JPY 0.0%
2022 - JPY 0.0%
2021 - JPY 0.0%

Peer Revenue Comparison of K Pharma,Inc.

Name Revenue Revenue Difference
KOHJIN BIO CO LTD 4.77 Billion JPY 79.036%
PRISM BioLab Co.,LTD 112.92 Million JPY -785.536%
GNI Group Ltd. 26.01 Billion JPY 96.155%
Linical Co., Ltd. 12.3 Billion JPY 91.875%
Trans Genic Inc. 13.08 Billion JPY 92.357%
MEDINET Co., Ltd. 661.54 Million JPY -51.162%
Soiken Holdings Inc. 5.15 Billion JPY 80.614%
Cytori Cell Research Institute, Inc. 1.56 Billion JPY 35.913%
AnGes, Inc. 152.98 Million JPY -553.659%
OncoTherapy Science, Inc. 610.11 Million JPY -63.903%
Nxera Pharma Co., Ltd. 12.76 Billion JPY 92.167%
Immuno-Biological Laboratories Co., Ltd. 816.7 Million JPY -22.444%
NanoCarrier Co., Ltd. 135.5 Million JPY -637.964%
Carna Biosciences, Inc. 1.62 Billion JPY 38.495%
CanBas Co., Ltd. - JPY -Infinity%
D. Western Therapeutics Institute, Inc. 428.36 Million JPY -133.446%
RaQualia Pharma Inc. 1.9 Billion JPY 47.402%
Chiome Bioscience Inc. 682.46 Million JPY -46.528%
Kidswell Bio Corporation 2.43 Billion JPY 58.869%
PeptiDream Inc. 28.71 Billion JPY 96.517%
Oncolys BioPharma Inc. 63.03 Million JPY -1486.345%
Ribomic Inc. - JPY -Infinity%
SanBio Company Limited - JPY -Infinity%
Healios K.K. 121 Million JPY -726.446%
BrightPath Biotherapeutics Co., Ltd. 72 Thousand JPY -1388788.889%
Kubota Pharmaceutical Holdings Co., Ltd. 39.88 Million JPY -2407.083%
Delta-Fly Pharma, Inc. - JPY -Infinity%
StemRIM - JPY -Infinity%
CellSource Co., Ltd. 4.51 Billion JPY 77.83%
FunPep Company Limited 530 Thousand JPY -188579.245%
Kringle Pharma, Inc. 69.25 Million JPY -1344.043%
Stella Pharma Corporation 269.49 Million JPY -271.07%
TMS Co., Ltd. - JPY -Infinity%
Noile-Immune Biotech Inc. 316.81 Million JPY -215.639%
Cuorips Inc. 23.1 Million JPY -4228.63%
Takara Bio Inc. 43.5 Billion JPY 97.701%
ReproCELL Incorporated 2.42 Billion JPY 58.794%
PhoenixBio Co., Ltd. 1.71 Billion JPY 41.702%
StemCell Institute Inc. 2.48 Billion JPY 59.697%
Japan Tissue Engineering Co., Ltd. 2.51 Billion JPY 60.226%
CellSeed Inc. 190.13 Million JPY -425.945%